Educational Courses by HTA


COURSE OVERVIEW

Pricing is of growing importance and complexity of all effective marketing and corporate strategies. Strategically, pricing has a direct impact on a company’s profitability, long-term sustainability and innovativeness, brand and corporate image, marketing and distribution effectiveness, and customer relationship management.
This course aims to develop awareness about pricing and reimbursement. In a situation of very complex environment in terms of regulations, HTA and pharmacoeconomics, and cost containment measures, the value proposition is of a key importance in order to grant best medication within the existing financial limits. The better understanding of cost/price/value concept, internal and external price referencing and its consequences, price decrease impact on company P&L etc. will enable the team to increase understanding about the added value and the importance of medicinal products which are protecting human life, well-being and productivity.

OBJECTIVES OF COURSE

  • To improve pricing awareness;
  • To shape the perception about price importance
  • Reinforce the execution of the pricing strategies
  • Support communication within the company and with respective local pricing bodies (HAs)
  • Minimize the impact of local pricing regulation
  • Managing different pricing issues

THE COURSE IS AIMED AT MEMBERS OF:

This course is suitable for anyone whose responsibilities/porfolio includes setting prices for their products and services:

  • Executive managers
  • Marketing, product, brand and sales managers, incl. medical department
  • Retail managers
  • Distribution managers
  • Product development managers
  • Business Owners

TOPICS TO BE COVERED:

  1. The ‘concept’ of price
  2. Key drivers of price
  3. The importance of price optimization
  4. Introduction to HTA
  5. The utilization of pharmacoeconomic evaluations
  6. Free market concept
  7. Negotiation with more powerful
  8. Basics of risk management

DURATION OF THE COURSE:

2 days course, if all topics covered.

Please, send your questions to: specify@hta.bg


COURSE OVERVIEW

Market access is a discipline that is increasingly critical to the pharmaceutical sector around the world. The theoretical and practical training of experts from various areas including pharmaceutical industry is increasingly triggered by the rapid development of science, the assessment of health technologies, the various practices in the application of theory, and frequent regulatory changes.

The way senior management manage the risks associated with the introduction of new products to the market also changes. The position of market access manager has significantly changed its meaning and content, its requirements have risen sharply,
requiring an assimilation of new concepts, principles and competencies, as well as close cooperation with all other departments in the company – medical, regulatory, marketing, sales, etc.

This course aims to help managers with the experience of being more effective and successful in achieving their professional goals from the market access perspective. The course will discuss many examples of market access reality.

THE COURSE IS AIMED AT:

The course is suitable for pharmaceutical industry executives with at least 5 years of experience – medical, regulatory, market access, marketing, sales departments.

TOPICS TO BE COVERED:

  1. Current trends in the European drug policy
  2. Basic terminology in the assessment of health technologies
  3. Concept of Health Technology Assessment
  4. Role of Health Technology Assessment
  5. Principles in Health Technology Assessment
  6. Pharmacoeconomic aspects of Market Access
  7. Key steps in the preparation of the HTA dossier
  8. Selection of clinical trials for inclusion in the HTA dossier
  9. Selection of comparators in the HTA dossier
  10. Types of economic analyses in HTA
  11. Budgetary impact analysis
  12. Sensitivity analysis
  13. The role of the MAH in the preparation of the HTA dossier
  14. Type and role of thresholds
  15. Real life data
  16. Patient registers
  17. Various examples from practice.

DURATION OF THE COURSE:

2 days course, if all topics covered.

Please, send your questions to: specify@hta.bg


COURSE OVERVIEW

Health Technology Assessment (HTA) has been defined by the International Network of Agencies for HTA (INAHTA) as “a multidisciplinary field of policy analysis studying the medical, economic, social, and ethical implications of development, diffusion and use of health technologies (e. g., drugs, devices, surgical procedures, prevention techniques)”. In conducting HTA, the discipline of decision sciences has become increasingly relevant.

This introductory course covers the key elements and methods of HTA and combines lectures and discussions.

THE COURSE IS AIMED AT:

  • Healthcare & health policy organizations, National HTA – Agencies
  • Pharmaceutical & medical device industry
  • Academia and research institutions
  • Health insurances/sick funds
  • Consultancy organizations

OBJECTIVES OF COURSE

By the end of the course, participants will be familiar with:

  • HTA principles and practice
  • Methods in biostatistics, clinical epidemiology and EbM
  • Patient-relevant outcome measures
  • Critical study appraisal
  • Systematic reviews & meta-analysis
  • Economic evaluation and pricing
  • Decision-analytic modeling
  • Context-specific application of HTA
  • HTA from different perspectives (agency, industry, etc.)

TOPICS TO BE COVERED:

  1. Key aspects in health technology assessment
  2. Concept of health technology assessment
  3. Key aspects in health technology assessment
  4. Concept of health technology assessment
  5. The role of health technology assessment
  6. Principles of health technology assessment
  7. Pharmacoeconomic aspects of market access
  8. Main steps in hta dossiers preparation
  9. Selection of clinical trials for inclusion in hta dossier
  10. Selection of comparators for hta submissions
  11. Types of economic analysis used in hta
  12. Budgetary impact analysis
  13. Sensitivity analysis
  14. The role of mah in hta dossiers preparation
  15. Types and role of threshold
  16. Real life data
  17. Patient registry
  18. Examples related to hta practice in Bulgaria

DURATION OF THE COURSE:

2 days course, if all topics covered.

Please, send your questions to: specify@hta.bg


COURSE OVERVIEW

The need for knowledge in the area of epidemiology and biostatistics is becoming increasingly essential in the practice of modern medicine, the handling and creation of scientific information, the participation in multidisciplinary teams working in the field of public health, the management of clinical trials, health insurance, health policy, etc.

The course in epidemiology and biostatistics aims to provide participants with theoretical and practical skills in planning and conducting epidemiological studies, including skills for planning their own research projects using modern methods of
Epidemiology. It also aims to provide expertise in epidemiological analysis as well as theoretical and practical knowledge required for competence in major biostatical analysis.

The course aims to develop practical skills in the participants, so in the program for
each of the three days there are also practical exercises – application of the theory in
practice.

THE COURSE IS AIMED AT:

  • Public health professionals
  • Health policy specialists
  • Medical managers from the pharmaceutical industry
  • Medical managers from the medical devices and diagnostic products industries
  • Specialists in academic and research centers
  • Students and PhD students
  • People working in organizations that run clinical research programs
  • Specialists from health insurance funds
  • Consultancy companies

TOPICS TO BE COVERED:

  1. Introduction to epidemiology
    1. Definition
    2. History
    3. Purpose
    4. Epidemiological approach and epidemiological methods
  2. Types of epidemiological studies
    1. Observational epidemiological studies
      1. Descriptive epidemiological studies
      2. Analytical epidemiological studies
    2. Experimental epidemiological studies
    3. Strengths and weaknesses of the different types of epidemiological studies
    4. Potential errors in conducting of and analysing data frome pidemiological studies
  3. Risk analysis in epidemiological studies
    1. Risk indicators
    2. Causal connection
    3. Public health significance
  4. Data handling
    1. Variables
    2. Frequency
    3. Distribution
    4. Data aggregation methods
    5. Distribution parameters
    6. Sample
  5. Health and disease measures
    1. Coefficient, ratio, index
    2. Incidence, prevalence, mortality
    3. Standardization
  6. Prophylaxis and prevention
    1. Primary
    2. Secondary
    3. Tertiary
    4. Screening
  7. Epidemiology of Infectious Diseases
  8. Epidemiology in Public Health and Health Policy
  9. Critical analysis of publications in the field of epidemiology
  10. Principles of biostatistical analysis and its application in the processing of
    data from epidemiological studies.
  11. Descriptive Biostatistics. Data distribution and dissipation. Frequency tables, frequency
  12. Analytical Biostatistics. Statistical laws, tendencies, mutual relationships, dependencies.
  13. Hypothesis verification. Correlation and regression analysis.
  14. Calculation of risk, chance, relative risk, odds ratio, attribute risk, population attribute risk
  15. Practical activities

DURATION OF THE COURSE:

3 days course, if all topics covered.
Please, send your questions to: specify@hta.bg